Predicting the prognosis of epithelial ovarian cancer patients based on deep learning models

  • 0Department of Epidemiology and Health Statistics, Dalian Medical University, Dalian, China.

|

|

Summary

This summary is machine-generated.

This study developed prognostic models to predict overall survival in epithelial ovarian cancer patients. The DeepSurv machine learning model demonstrated the best predictive performance, aiding clinical decision-making.

Area Of Science

  • Oncology
  • Biostatistics
  • Machine Learning in Healthcare

Background

  • Epithelial ovarian cancer (EOC) presents high mortality and morbidity rates.
  • Accurate prognostic models are crucial for improving survival outcomes in EOC patients.

Purpose Of The Study

  • To develop and validate prognostic models for predicting overall survival (OS) in epithelial ovarian cancer (EOC) patients.
  • To compare the performance of machine learning (ML) models against traditional regression methods.

Main Methods

  • Utilized SEER database (N=10902) and a hospital-based cohort (N=116) for model development and validation.
  • Employed COX regression for prognostic factor identification and developed three ML models (including DeepSurv) and a nomogram.
  • Evaluated models using C-index, ROC curves, calibration curves, and decision curve analysis (DCA).

Main Results

  • Identified 12 independent prognostic factors for OS in EOC patients.
  • The DeepSurv model exhibited superior performance, with a C-index of 0.715 (internal) and 0.672 (external validation).
  • Achieved high accuracy in predicting 3- and 5-year survival rates, with ROC curves ranging from 0.731 to 0.766.

Conclusions

  • Successfully developed and validated multiple predictive models, including a nomogram and ML-based approaches.
  • The DeepSurv model shows significant potential as a clinical decision support tool for EOC patient management.
  • These models offer valuable instruments for predicting overall survival and guiding treatment strategies in epithelial ovarian cancer.